- Home
- QNRX vs NVVE Comparison
QNRX vs NVVE Comparison
Compare QNRX & NVVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QNRX
- NVVE
- Stock Information
- Founded
- QNRX 2018
- NVVE 1996
- Country
- QNRX United States
- NVVE United States
- Employees
- QNRX N/A
- NVVE N/A
- Industry
- QNRX Medical/Dental Instruments
- NVVE Oil Refining/Marketing
- Sector
- QNRX Health Care
- NVVE Energy
- Exchange
- QNRX Nasdaq
- NVVE Nasdaq
- Market Cap
- QNRX 4.8M
- NVVE 4.2M
- IPO Year
- QNRX N/A
- NVVE N/A
- Fundamental
- Price
- QNRX $15.56
- NVVE $0.23
- Analyst Decision
- QNRX
- NVVE
- Analyst Count
- QNRX 0
- NVVE 0
- Target Price
- QNRX N/A
- NVVE N/A
- AVG Volume (30 Days)
- QNRX 850.8K
- NVVE 1.8M
- Earning Date
- QNRX 11-06-2025
- NVVE 11-11-2025
- Dividend Yield
- QNRX N/A
- NVVE N/A
- EPS Growth
- QNRX N/A
- NVVE N/A
- EPS
- QNRX N/A
- NVVE N/A
- Revenue
- QNRX N/A
- NVVE $4,949,747.00
- Revenue This Year
- QNRX N/A
- NVVE $892.33
- Revenue Next Year
- QNRX N/A
- NVVE N/A
- P/E Ratio
- QNRX N/A
- NVVE N/A
- Revenue Growth
- QNRX N/A
- NVVE N/A
- 52 Week Low
- QNRX $5.01
- NVVE $0.18
- 52 Week High
- QNRX $54.95
- NVVE $5.02
- Technical
- Relative Strength Index (RSI)
- QNRX 66.15
- NVVE 34.95
- Support Level
- QNRX $12.31
- NVVE $0.21
- Resistance Level
- QNRX $41.80
- NVVE $0.28
- Average True Range (ATR)
- QNRX 3.40
- NVVE 0.03
- MACD
- QNRX 0.95
- NVVE 0.01
- Stochastic Oscillator
- QNRX 24.75
- NVVE 19.34
About QNRX Quoin Pharmaceuticals Ltd.
Quoin Pharmaceuticals Ltd is a clinical stage specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. Its pipeline comprises three products that collectively have the potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Epidermolysis Bullosa, and others.
About NVVE Nuvve Holding Corp.
Nuvve Holding Corp is accelerating the electrification of transportation through its proprietary vehicle-to-grid (V2G) technology. It helps to support the integration of renewable energy sources, including solar and wind. Its Grid Integrated Vehicle (GIV) platform is refueling the next generation of electric vehicle fleets through bidirectional charging solutions. It has a geographic presence in the United States, the United Kingdom, and Denmark, of which it generates the majority of its revenue in the United States.